Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

The COMPASSION Study

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient of any gender with unresectable locally advanced or metastatic breast cancer - Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment - Ability to conduct video or phone check-ins, even if assistance required. - Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able - Hospice setting is within Massachusetts - Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team - Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment Who Should NOT Join This Trial: - Unable to provide verbal consent - Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting) - Hospice setting outside of Massachusetts - Individuals who are under the age of 18, as this is not a project focused on pediatric patients. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient of any gender with unresectable locally advanced or metastatic breast cancer * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment * Ability to conduct video or phone check-ins, even if assistance required. * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able * Hospice setting is within Massachusetts * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment Exclusion Criteria: * Unable to provide verbal consent * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting) * Hospice setting outside of Massachusetts * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Treatments Being Tested

OTHER

Telehealth Hospice Visits

Telehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.

Locations (1)

Dana-Farber Cancer Institute
Boston, Massachusetts, United States